"Gadolinium DTPA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
| Descriptor ID |
D019786
|
| MeSH Number(s) |
D02.092.782.590.401 D02.241.081.018.639.400 D02.691.400
|
| Concept/Terms |
Gadolinium DTPA- Gadolinium DTPA
- DTPA, Gadolinium
- Gadolinium Diethylenetriaminepenta-acetic Acid
- Diethylenetriaminepenta-acetic Acid, Gadolinium
- Gadolinium Diethylenetriaminepenta acetic Acid
- Gadopentetic Acid
- Gd-DTPA
- Gd DTPA
Gadopentetate Dimeglumine- Gadopentetate Dimeglumine
- Dimeglumine, Gadopentetate
- Gadolinium DTPA Dimeglumine Salt
- Gadolinium DTPA Dimeglumine
- Dimeglumine, Gadolinium DTPA
|
Below are MeSH descriptors whose meaning is more general than "Gadolinium DTPA".
Below are MeSH descriptors whose meaning is more specific than "Gadolinium DTPA".
This graph shows the total number of publications written about "Gadolinium DTPA" by people in this website by year, and whether "Gadolinium DTPA" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 3 | 5 | 8 |
| 2018 | 7 | 8 | 15 |
| 2019 | 1 | 5 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Gadolinium DTPA" by people in Profiles.
-
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group. Eur Heart J Cardiovasc Imaging. 2019 Sep 01; 20(9):1004-1011.
-
Comment on "State of the art in magnetic resonance imaging of hepatocellular carcinoma": the role of DWI. Radiol Oncol. 2019 07 13; 53(3):369-370.
-
Estimating liver function in a large cirrhotic cohort: Signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI. Dig Liver Dis. 2019 10; 51(10):1438-1445.
-
Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma. J Hepatol. 2019 09; 71(3):534-542.
-
Temporal course and implications of intracranial atherosclerotic plaque enhancement on high-resolution vessel wall MRI. Neuroradiology. 2019 Jun; 61(6):651-657.
-
Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis. Int J Cardiovasc Imaging. 2019 Jun; 35(6):1067-1078.
-
Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis. Radiology. 2019 02; 290(2):380-387.
-
Accuracy of diffusion-weighted imaging-magnetic resonance in differentiating functional from non-functional pituitary macro-adenoma and classification of tumor consistency. Neuroradiol J. 2019 Apr; 32(2):74-85.
-
Gadolinium presence, MRI hyperintensities, and glucose uptake in the hypoperfused rat brain after repeated administrations of gadodiamide. Neuroradiology. 2019 Feb; 61(2):163-173.
-
Association of left ventricular late gadolinium enhancement with left atrial low voltage areas in patients with atrial fibrillation. Europace. 2018 10 01; 20(10):1606-1611.